Kenneth Bender, PharmD, MA


Hepatitis D Characterized as Most Severe, Progressive Viral Hepatitis

Review of hepatitis D virus describes “unique” biologic characteristics and “ominous” medical effect, but constrained as HBV treatments affect HDV life cycle.

Madeline King, PharmD, BCIDP*


Future of Fluoroquinolones: Risks, Benefits of Antibiotic Workhorse

Warnings and concerns regarding fluoroquinolones are on the rise, but the antibiotics still play a role, albeit more limited, in the treatment of various infectious diseases.

Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS


Final Thoughts on COVID-19 and Flu

Final thoughts from experts on controlling COVID-19 and influenza.

Saskia v. Popescu


Addressing ART Adherence in Hispanic/Latino Men Living with HIV

Investigators found these populations are younger and are living at or below poverty were at lower adherence to ART.

Alan Gross, PharmD, BCPS-AQ-ID


A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet Need

This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.

Catherine Kolonko


Testing Still Needed After HCV Clears in HIV-Positive MSM

A retrospective study found hepatitis C reinfection rates high are in HIV-positive men who have sex with men from four western European countries.

Lucia Rose, PharmD, BCIDP


Lefamulin: An Overview of a Lonely Soldier

Lefamulin, a recently approved pleuromutilin, adds to the current antibiotic armamentarium, although its place in therapy remains to be seen.

Panelist: Thomas Lodise, PharmD, PhD


IDWeek 2019 News Network: Assessing Challenges to Treating CABP

Thomas Lodise, PharmD, PhD, provides an overview of options for treating community-acquired bacterial pneumonia and highlights the challenges of the infection.

Gale Scott


Ebola Vaccine Offers 100% Protection Against Deadly Virus

Researchers have found that an experimental vaccine designed to fight the Ebola virus has proven to be highly protective.

Amanda Roy, PharmD


Intraseasonal Influenza Vaccine Effectiveness Waning: Threading the Needle for Immunity

Evidence is accumulating that influenza vaccination protection wanes over the course of a single influenza season, with significant implications for public health.

Matt Hoffman


Infectious Agent May Drive Alzheimer Disease Pathology

New research has suggested that Alzheimer disease pathology may be driven by an infectious agent, Porphyromonas gingivalis.



The Multi-Drug Resistant Organism Network

A collaborative, international effort aims to answer tough antimicrobial resistance questions.

Laurie Saloman


Preventing Multidrug-Resistant Spread in Healthcare Facilities

The interconnectedness of many healthcare facilities such as nursing homes, hospitals, and long-term acute-care hospitals means a significant chance of multidrug-resistant organism transmission when patients shuttle between facilities.

Brian McCullough, PharmD, BCPS


Shoutout to the Stewards: Holiday Edition

Contagion® radio is here to bring joy with every new antibiotic alert!

Katie Eder


How Obamacare Will Affect HIV/AIDS Prevention

Noting successful HIV/AIDS prevention efforts rely on early diagnosis, an analysis estimates that improved access to health insurance through the Affordable Care Act will increase the number of patients getting tested for HIV by nearly 500,000 over a 5-year period, though that impact would be amplified if all US states opted to expand Medicaid coverage.

Contagion Staff


President Trump and First Lady Test Positive for COVID-19

President Donald Trump broke the news last night via Twitter.

Shelby Leheny, PharmD, BS


Taking A Closer Look at Shingrix: The New Shingles Vaccine

The only way individuals can reduce their risk of getting shingles is to get vaccinated; luckily, a new vaccine has recently been approved by the FDA.



An Unknown Contagious Rash: Case Report and Literature Review of Norwegian Crusted Scabies

A patient with HIV and skin lesions should trigger a broad differential.

Samantha DiGrande


Fecal Transplant Benefits C diff Patients Coinfected With COVID-19

Treating Clostridioides difficile infection is complicated in patients coinfected with COVID-19. However, a new study suggests a significant benefit of fecal microbiota transplant (FMT) in these coinfected patients.

Michael B. Henry, MD


Four Fungal Horsemen: Emerging Trends in Fungal Disease Epidemiology

New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.

E. Kelly Hester, PharmD


Antiretroviral Safety in Pregnancy: Focus on Dolutegravir, Integrase Inhibitors, and Neural Tube Defects

There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.

Colleen Hall


Pediatric Hexavalent Combination Vaccine Approved by FDA

The vaccine is approved as a 3-dose series, which consists of a 0.5 mL intramuscular injection, administered at 2, 4, and 6 months of age.



Alternative Antiretroviral Medication Delivery Systems Emerge to Treat, Prevent HIV Infection

Novel modes of delivery are imperative to improve HIV suppression and prevent transmission.

Jenna Payesko


FDA Grants QIDP & Fast Track Designations for SCY-078 to Treat Vulvovaginal Candidiasis

The FDA has granted QIDP and Fast Track Designations for the oral formulation of SCY-078 for the treatment of vulvovaginal candidiasis.

Mathew Shanley


Strategic Alliance Formed to Advance RNAi Therapeutics for Infectious Diseases

Alnylam Pharmaceuticals announces exclusive licensing agreement with Vir Biotechnology for the development and commercialization of RNA Interference therapeutics for infectious diseases.

Monika Schneider, PhD


New Rules Expand Application of the NTAP Program for Innovative Antibiotics

To better support the use of critical antibiotics, the Centers for Medicare & Medicaid Services revised the rules governing reimbursement for qualifying antibiotic products. For these changes to succeed, hospital systems will need to make adjustments.

© 2023 MJH Life Sciences

All rights reserved.